Clinical Site

Lübeck 23538

1 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulopathy (C3G), Hidradenitis Suppurativa

Studies at this site

• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed